• Facebook
  • Twitter
  • LinkedIn
  • Google +
  • RSS

Genentech - Articles and news items

FDA approves Xolair to treat allergic asthma in children

Industry news / 11 July 2016 / Victoria White, Digital Content Producer

The FDA has approved Genentech’s Xolair (omalizumab) to treat moderate to severe persistent asthma in children six to 11 years of age…

Daratumumab and atezolizumab to be evaluated in two studies

Industry news / 22 March 2016 / Victoria White

The studies will assess the combination of daratumumab and atezolizumab in multiple myeloma and in solid tumour cancer…

FDA approves Gazyva to treat follicular lymphoma

Industry news / 1 March 2016 / Victoria White

The FDA has approved Gazyva (obinutuzumab) plus bendamustine chemotherapy followed by Gazyva alone as a new treatment for people with follicular lymphoma…

FDA grants third venetoclax Breakthrough Therapy Designation

Industry news / 28 January 2016 / Victoria White

The designation is for venetoclax in combination with HMAs for the treatment of patients with untreated AML who are ineligible to receive standard induction therapy…

Astellas logo

FDA approves Tarceva (Erlotinib) tablets for specific type of lung cancer

Industry news, News / 15 May 2013 / Astellas Pharma Inc.

The FDA also approved the cobas® EGFR Mutation Test, which was developed by Roche and validated in the pivotal EURTAC study…

Gilead logo

Gilead Sciences to purchase biologics process research and clinical manufacturing facility from Genentech

Industry news, News / 8 August 2011 / Gilead Sciences Inc

Gilead Sciences, Inc. has signed a definitive agreement…